Resolution of cell-mediated airways diseases

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Persson, Carl G ^a   Uller, Lena ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY; APOPTOSIS; ASTHMA; CELL MIGRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DENDRITIC CELL; EOSINOPHIL; GRANULOCYTE; HUMAN; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE; MAST CELL; MOLECULAR MECHANICS; MUCOCILIARY CLEARANCE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; REGULON; RESPIRATORY EPITHELIUM; REVIEW; ANIMAL; CELL MOTION; DRUG EFFECT; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT MUCOSA;

ANTIINFLAMMATORY AGENT; AUTACOID;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ASTHMA; CELL MOVEMENT; EOSINOPHILS; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES; LUNG; LYMPHOCYTES; MAST CELLS; MUCOCILIARY CLEARANCE; NEUTROPHILS; PHAGOCYTOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; RESPIRATORY TRACT DISEASES;

EID: 77956686601     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-75     Document Type: Review

References (144)

1. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007, 21(2):325-332. 10.1096/fj.06-7227rev, 17267386.
2. Downey DG, Bell SC, Elborn JS. Neutrophils in cystic fibrosis. Thorax 2009, 64(1):81-88. 10.1136/thx.2007.082388, 19103874.
3. Porter JC. Epithelial Rho GTPases and the transepithelial migration of lymphocytes. Methods Enzymol 2008, 439:205-217. full_text, 2610464, 18374167.
4. Persson CG. In vivo veritas: the continuing importance of discoveries in complex biosystems. Thorax 1996, 51(4):441-443. 10.1136/thx.51.4.441, 1090685, 8733502.
5. Persson C. Discoveries in complex biosystems. Nat Biotechnol 1997, 15(10):927. 10.1038/nbt1097-927a, 9335034.
6. Persson CG, Erjefalt JS, Uller L, Andersson M, Greiff L. Unbalanced research. Trends Pharmacol Sci 2001, 22(10):538-541. 10.1016/S0165-6147(00)01839-3, 11583812.
7. Persson CG, Erjefalt JS. Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development. Trends Pharmacol Sci 1997, 18(4):117-123. 10.1016/S0165-6147(97)01042-0, 9149540.
8. Uller L, Andersson M, Greiff L, Persson CG, Erjefalt JS. Occurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps. Am J Respir Crit Care Med 2004, 170(7):742-747. 10.1164/rccm.200402-240OC, 15229095.
9. Persson CG. Centennial notions of asthma as an eosinophilic, desquamative, exudative, and steroid-sensitive disease. Lancet 1997, 350(9083):1021-1024. 10.1016/S0140-6736(96)02335-5, 9329527.
10. Erjefalt JS, Persson CG. New aspects of degranulation and fates of airway mucosal eosinophils. Am J Respir Crit Care Med 2000, 161(6):2074-2085.
11. Uller L, Persson CG, Kallstrom L, Erjefalt JS. Lung tissue eosinophils may be cleared through luminal entry rather than apoptosis: effects of steroid treatment. Am J Respir Crit Care Med 2001, 164(10 Pt 1):1948-1956.
12. Greiff L, Erjefalt JS, Andersson M, Svensson C, Persson CG. Generation of clusters of free eosinophil granules (Cfegs) in seasonal allergic rhinitis. Allergy 1998, 53(2):200-203. 10.1111/j.1398-9995.1998.tb03871.x, 9534921.
13. Uller L, Persson CG, Erjefalt JS. Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both?. Trends Pharmacol Sci 2006, 27(9):461-466. 10.1016/j.tips.2006.07.006, 16876880.
14. Persson C, Uller L. Roles of plasma exudation in asthma and COPD. Clin Exp Allergy 2009, 39(11):1626-1629. 10.1111/j.1365-2222.2009.03373.x, 19860815.
15. Zemans RL, Colgan SP, Downey GP. Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol 2009, 40(5):519-535. 10.1165/rcmb.2008-0348TR, 2677434, 18978300.
16. Erjefalt JS, Uller L, Malm-Erjefalt M, Persson CG. Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration. Thorax 2004, 59(2):136-143. 10.1136/thorax.2003.004218, 1746951, 14760154.
17. Porter JC, Falzon M, Hall A. Polarized localization of epithelial CXCL11 in chronic obstructive pulmonary disease and mechanisms of T cell egression. J Immunol 2008, 180(3):1866-1877. 2274894, 18209084.
18. Liu L, Mul FP, Lutter R, Roos D, Knol EF. Transmigration of human neutrophils across airway epithelial cell monolayers is preferentially in the physiologic basolateral-to-apical direction. Am J Respir Cell Mol Biol 1996, 15(6):771-780.
19. Kato Y, Fujisawa T, Shibano M, Saito T, Gatto W, Kamiya H, Hirai K, Sumida M, Yoshie O. Airway epithelial cells promote transmigration of eosinophils in a new three-dimensional chemotaxis model. Clin Exp Allergy 2002, 32(6):889-897. 10.1046/j.1365-2222.2002.01362.x, 12047436.
20. Lehmann C, Wilkening A, Leiber D, Markus A, Krug N, Pabst R, Tschernig T. Lymphocytes in the bronchoalveolar space reenter the lung tissue by means of the alveolar epithelium, migrate to regional lymph nodes, and subsequently rejoin the systemic immune system. Anat Rec 2001, 264(3):229-236. 10.1002/ar.1163, 11596005.
21. Erjefalt I, Luts A, Persson CG. Appearance of airway absorption and exudation tracers in guinea pig tracheobronchial lymph nodes. J Appl Physiol 1993, 74(2):817-824.
22. Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997, 185(5):885-892. 10.1084/jem.185.5.885, 2196175, 9120394.
23. Buckley CD, Ross EA, McGettrick HM, Osborne CE, Haworth O, Schmutz C, Stone PC, Salmon M, Matharu NM, Vohra RK, Nash GB, Rainger GE. Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J Leukoc Biol 2006, 79(2):303-311. 10.1189/jlb.0905496, 16330528.
24. McGettrick HM, Hunter K, Moss PA, Buckley CD, Rainger GE, Nash GB. Direct observations of the kinetics of migrating T cells suggest active retention by endothelial cells with continual bidirectional migration. J Leukoc Biol 2009, 85(1):98-107. 10.1189/jlb.0508301, 2626767, 18948550.
25. Haworth O, Buckley CD. Resolving the problem of persistence in the switch from acute to chronic inflammation. Proc Natl Acad Sci USA 2007, 104(52):20647-20648. 10.1073/pnas.0710633105, 2409206, 18093938.
26. Uller L, Lloyd CM, Rydell-Tormanen K, Persson CG, Erjefalt JS. Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation. Clin Exp Allergy 2006, 36(1):111-121. 10.1111/j.1365-2222.2006.02396.x, 16393273.
27. Uller L, Ahlstrom Emanuelsson C, Andersson M, Erjefalt JS, Greiff L, Persson CG. Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis. Respir Res 2010, 11(1):54. 10.1186/1465-9921-11-54, 2873933, 20459697.
28. Spinozzi F, de Benedictis D, de Benedictis FM. Apoptosis, airway inflammation and anti-asthma therapy: from immunobiology to clinical application. Pediatr Allergy Immunol 2008, 19(4):287-295. 10.1111/j.1399-3038.2007.00668.x, 18179617.
29. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991, 147(10):3490-3495.
30. Brunetti M, Martelli N, Colasante A, Piantelli M, Musiani P, Aiello FB. Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood 1995, 86(11):4199-4205.
31. Wissinger E, Goulding J, Hussell T. Immune homeostasis in the respiratory tract and its impact on heterologous infection. Semin Immunol 2009, 21(3):147-155. 10.1016/j.smim.2009.01.005, 19223202.
32. Uller L, Bedke N, Sammut D, Green B, Howarth P, Holgate S, Davies D. Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from asthmatic donors. Thorax 2010,
33. Larche M. Regulatory T cells in allergy and asthma. Chest 2007, 132(3):1007-1014. 10.1378/chest.06-2434, 17873195.
34. Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res 2009, 2923754, 19769993.
35. Dumas A, Pouliot M. [Neutrophil: foe or friend?]. Med Sci (Paris) 2009, 25(8-9):699-704.
36. Lawrence T, Fong C. The resolution of inflammation: Anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Biol 2009, 42(4):519-23. 10.1016/j.biocel.2009.12.016, 20026420.
37. Anderson P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 10(1):24-35. 10.1038/nri2685, 20029446.
38. Van Hove CL, Maes T, Joos GF, Tournoy KG. Chronic inflammation in asthma: a contest of persistence vs resolution. Allergy 2008, 63(9):1095-1109. 10.1111/j.1398-9995.2008.01772.x, 18616676.
39. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996, 154(1):237-243.
40. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med 2001, 163(1):32-36.
41. Walsh GM. Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins?. Trends Pharmacol Sci 2008, 29(1):6-11. 10.1016/j.tips.2007.11.002, 18054798.
42. Rytila P, Plataki M, Bucchieri F, Uddin M, Nong G, Kinnula VL, Djukanovic R. Airway neutrophilia in COPD is not associated with increased neutrophil survival. Eur Respir J 2006, 28(6):1163-1169. 10.1183/09031936.00149005, 16971404.
43. Watt AP, Courtney J, Moore J, Ennis M, Elborn JS. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax 2005, 60(8):659-664. 10.1136/thx.2004.038240, 1747479, 16061707.
44. Watt AP, Brown V, Courtney J, Kelly M, Garske L, Elborn JS, Ennis M. Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax 2004, 59(3):231-236. 10.1136/thx.2003.008037, 1746966, 14985560.
45. Matute-Bello G, Martin TR. Science review: apoptosis in acute lung injury. Crit Care 2003, 7(5):355-358. 10.1186/cc1861, 270707, 12974968.
46. Kotecha S, Mildner RJ, Prince LR, Vyas JR, Currie AE, Lawson RA, Whyte MK. The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants. Thorax 2003, 58(11):961-967. 10.1136/thorax.58.11.961, 1746501, 14586049.
47. Druilhe A, Wallaert B, Tsicopoulos A, Lapa e Silva JR, Tillie-Leblond I, Tonnel AB, Pretolani M. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol 1998, 19(5):747-757.
48. O'Sullivan S, Cormican L, Burke CM, Poulter LW. Fluticasone induces T cell apoptosis in the bronchial wall of mild to moderate asthmatics. Thorax 2004, 59(8):657-661. 10.1136/thx.2002.001586, 1747107, 15282384.
49. Hodge S, Hodge G, Holmes M, Reynolds PN. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 2005, 25(3):447-454. 10.1183/09031936.05.00077604, 15738287.
50. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995, 154(9):4719-4725.
51. Gizycki MJ, Hattotuwa KL, Barnes N, Jeffery PK. Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax 2002, 57(9):799-803. 10.1136/thorax.57.9.799, 1746422, 12200525.
52. Bourbeau J, Christodoulopoulos P, Maltais F, Yamauchi Y, Olivenstein R, Hamid Q. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax 2007, 62(11):938-943. 10.1136/thx.2006.071068, 2117108, 17557771.
53. Reid DW, Wen Y, Johns DP, Williams TJ, Ward C, Walters EH. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related. Respirology 2008, 13(6):799-809. 10.1111/j.1440-1843.2008.01380.x, 18811878.
54. Fukakusa M, Bergeron C, Tulic MK, Fiset PO, Al Dewachi O, Laviolette M, Hamid Q, Chakir J. Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa. J Allergy Clin Immunol 2005, 115(2):280-286. 10.1016/j.jaci.2004.10.036, 15696082.
55. Nguyen LT, Lim S, Oates T, Chung KF. Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma. Respir Med 2005, 99(2):200-207. 10.1016/j.rmed.2004.06.007, 15715187.
56. Qiu Y, Zhu J, Bandi V, Guntupalli KK, Jeffery PK. Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax 2007, 62(6):475-482. 10.1136/thx.2006.066670, 2117215, 17234659.
57. Ozol D, Aysan T, Solak ZA, Mogulkoc N, Veral A, Sebik F. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients. Respir Med 2005, 99(12):1494-1500. 10.1016/j.rmed.2005.04.025, 15946834.
58. Barnes NC, Qiu YS, Pavord ID, Parker D, Davis PA, Zhu J, Johnson M, Thomson NC, Jeffery PK. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med 2006, 173(7):736-743. 10.1164/rccm.200508-1321OC, 16424444.
59. Vagaggini B, Cianchetti S, Bartoli M, Ricci M, Bacci E, Dente FL, Di Franco A, Paggiaro P. Prednisone blunts airway neutrophilic inflammatory response due to ozone exposure in asthmatic subjects. Respiration 2007, 74(1):61-68. 10.1159/000096078, 17028419.
60. Alexis NE, Lay JC, Haczku A, Gong H, Linn W, Hazucha MJ, Harris B, Tal-Singer R, Peden DB. Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers. Environ Health Perspect 2008, 116(6):799-805. 10.1289/ehp.10981, 2430237, 18560537.
61. Chin AC, Parkos CA. Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury. Annu Rev Pathol 2007, 2:111-143. 10.1146/annurev.pathol.2.010506.091944, 18039095.
62. Lukacs NW. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 2001, 1(2):108-116. 10.1038/35100503, 11905818.
63. Teran LM. CCL chemokines and asthma. Immunol Today 2000, 21(5):235-242. 10.1016/S0167-5699(00)01634-0, 10782055.
64. Moraes TJ, Rafii B, Niessen F, Suzuki T, Martin R, Vachon E, Vogel W, Ruf W, O'Brodovich H, Downey GP. Protease-activated receptor (Par)1 alters bioelectric properties of distal lung epithelia without compromising barrier function. Exp Lung Res 2009, 35(2):136-154. 10.1080/01902140802490723, 19263282.
65. Martin TR. Neutrophils and lung injury: getting it right. J Clin Invest 2002, 110(11):1603-1605. 151642, 12464663.
66. Persson CG, Erjefalt JS, Greiff L, Andersson M, Erjefalt I, Godfrey RW, Korsgren M, Linden M, Sundler F, Svensson C. Plasma-derived proteins in airway defence, disease and repair of epithelial injury. Eur Respir J 1998, 11(4):958-970. 10.1183/09031936.98.11040958, 9623704.
67. Persson C, Andersson M, Uller L. Epithelial repair and function. Pulmonary Epithelium 2008, 75-88. Chicester: Wiley, Proud D.
68. Aalbers R, de Monchy JG, Kauffman HF, Smith M, Hoekstra Y, Vrugt B, Timens W. Dynamics of eosinophil infiltration in the bronchial mucosa before and after the late asthmatic reaction. Eur Respir J 1993, 6(6):840-847.
69. Frew AJ, St-Pierre J, Teran LM, Trefilieff A, Madden J, Peroni D, Bodey KM, Walls AF, Howarth PH, Carroll MP, Holgate ST. Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways. J Allergy Clin Immunol 1996, 98(1):133-143. 10.1016/S0091-6749(96)70235-X, 8765827.
70. Brown JR, Kleimberg J, Marini M, Sun G, Bellini A, Mattoli S. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol 1998, 114(2):137-146. 10.1046/j.1365-2249.1998.00688.x, 1905105, 9822268.
71. Juliusson S, Pipkorn U, Karlsson G, Enerback L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992, 90(6 Pt 1):898-909. 10.1016/0091-6749(92)90462-B, 1281177.
72. Persson CG, Svensson C, Greiff L, Anderson M, Wollmer P, Alkner U, Erjefalt I. The use of the nose to study the inflammatory response of the respiratory tract. Thorax 1992, 47(12):993-1000. 10.1136/thx.47.12.993, 1021088, 1494783.
73. Crimi E, Chiaramondia M, Milanese M, Rossi GA, Brusasco V. Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis 1991, 144(6):1282-1286.
74. Gauvreau GM, Lee JM, Watson RM, Irani AM, Schwartz LB, O'Byrne PM. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med 2000, 161(5):1473-1478.
75. Lommatzsch M, Julius P, Kuepper M, Garn H, Bratke K, Irmscher S, Luttmann W, Renz H, Braun A, Virchow JC. The course of allergen-induced leukocyte infiltration in human and experimental asthma. J Allergy Clin Immunol 2006, 118(1):91-97. 10.1016/j.jaci.2006.02.034, 16815143.
76. Ichiyasu H, McCormack JM, McCarthy KM, Dombkowski D, Preffer FI, Schneeberger EE. Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am J Respir Cell Mol Biol 2004, 30(6):761-770. 10.1165/rcmb.2003-0370OC, 14656746.
77. Lambrecht BN, Carro-Muino I, Vermaelen K, Pauwels RA. Allergen-induced changes in bone-marrow progenitor and airway dendritic cells in sensitized rats. Am J Respir Cell Mol Biol 1999, 20(6):1165-1174.
78. Vermaelen K, Pauwels R. Accelerated airway dendritic cell maturation, trafficking, and elimination in a mouse model of asthma. Am J Respir Cell Mol Biol 2003, 29(3 Pt 1):405-409. 10.1165/rcmb.2003-0008OC, 12702544.
79. Bratke K, Lommatzsch M, Julius P, Kuepper M, Kleine HD, Luttmann W, Christian Virchow J. Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax 2007, 62(2):168-175. 10.1136/thx.2006.067793, 2111237, 16928719.
80. Bratke K, Klug M, Bier A, Julius P, Kuepper M, Virchow JC, Lommatzsch M. Function-associated surface molecules on airway dendritic cells in cigarette smokers. Am J Respir Cell Mol Biol 2008, 38(6):655-660. 10.1165/rcmb.2007-0400OC, 18203971.
81. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006, 368(9537):804-813. 10.1016/S0140-6736(06)69290-8, 16935691.
82. O'Donnell R, Breen D, Wilson S, Djukanovic R. Inflammatory cells in the airways in COPD. Thorax 2006, 61(5):448-454. 10.1136/thx.2004.024463, 2111192, 16648353.
83. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1185-1190.
84. Louhelainen N, Rytila P, Haahtela T, Kinnula VL, Djukanovic R. Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med 2009, 9:25. 10.1186/1471-2466-9-25, 2697135, 19473482.
85. Willemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Postma DS, Timens W. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 2005, 26(5):835-845. 10.1183/09031936.05.00108904, 16264044.
86. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, Jeffery PK. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 168(8):968-975. 10.1164/rccm.200208-794OC, 12857718.
87. Yoshihara S, Yamada Y, Abe T, Linden A, Arisaka O. Association of epithelial damage and signs of neutrophil mobilization in the airways during acute exacerbations of paediatric asthma. Clin Exp Immunol 2006, 144(2):212-216. 10.1111/j.1365-2249.2006.03058.x, 1809654, 16634793.
88. Mosser AG, Brockman-Schneider R, Amineva S, Burchell L, Sedgwick JB, Busse WW, Gern JE. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis 2002, 185(6):734-743. 10.1086/339339, 11920291.
89. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006, 173(10):1114-1121. 10.1164/rccm.200506-859OC, 16484677.
90. Snoeck-Stroband JB, Lapperre TS, Gosman MM, Boezen HM, Timens W, ten Hacken NH, Sont JK, Sterk PJ, Hiemstra PS. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies. Eur Respir J 2008, 31(1):70-77. 10.1183/09031936.00137006, 17804442.
91. Andersson CK, Mori M, Bjermer L, Lofdahl CG, Erjefalt JS. Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181(3):206-217. 10.1164/rccm.200906-0932OC, 19926870.
92. Tsuyuki S, Bertrand C, Erard F, Trifilieff A, Tsuyuki J, Wesp M, Anderson GP, Coyle AJ. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995, 96(6):2924-2931. 10.1172/JCI118364, 186004, 8675664.
93. Uller L, Rydell-Tormanen K, Persson CG, Erjefalt JS. Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation. Respir Res 2005, 6:90. 10.1186/1465-9921-6-90, 1187926, 16086832.
94. Gerwin N, Gonzalo JA, Lloyd C, Coyle AJ, Reiss Y, Banu N, Wang B, Xu H, Avraham H, Engelhardt B, et al. Prolonged eosinophil accumulation in allergic lung interstitium of ICAM-2 deficient mice results in extended hyperresponsiveness. Immunity 1999, 10(1):9-19. 10.1016/S1074-7613(00)80002-3, 10023766.
95. Corry DB, Kiss A, Song LZ, Song L, Xu J, Lee SH, Werb Z, Kheradmand F. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J 2004, 18(9):995-997. 2771179, 15059974.
96. Corry DB, Rishi K, Kanellis J, Kiss A, Song Lz LZ, Xu J, Feng L, Werb Z, Kheradmand F. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol 2002, 3(4):347-353. 10.1038/ni773, 2814346, 11887181.
97. Sorkness RL, Herricks KM, Szakaly RJ, Lemanske RF, Rosenthal LA. Altered allergen-induced eosinophil trafficking and physiological dysfunction in airways with preexisting virus-induced injury. Am J Physiol Lung Cell Mol Physiol 2007, 292(1):L85-91. 10.1152/ajplung.00234.2006, 16905639.
98. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003, 58(1):37-42. 10.1136/thorax.58.1.37, 1746460, 12511718.
99. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA, Holgate ST. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310(6989):1225-1229. 2549614, 7767192.
100. Seemungal TA, Wedzicha JA. Viral infections in obstructive airway diseases. Curr Opin Pulm Med 2003, 9(2):111-116. 10.1097/00063198-200303000-00004, 12574690.
101. Norman P. AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653. Expert Opin Ther Pat 2009, 19(11):1629-1633. 10.1517/13543770903118996, 19586423.
102. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000, 356(9248):2144-2148. 10.1016/S0140-6736(00)03496-6, 11191542.
103. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, Barnes N, Robinson D, Kay AB. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003, 112(7):1029-1036. 198522, 14523040.
104. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009, 360(10):973-984. 10.1056/NEJMoa0808991, 19264686.
105. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009, 360(10):985-993. 10.1056/NEJMoa0805435, 19264687.
106. Doerschuk CM. Leukocyte trafficking in alveoli and airway passages. Respir Res 2000, 1(3):136-140. 10.1186/rr24, 59559, 11667977.
107. Mitzner W, Lee W, Georgakopoulos D, Wagner E. Angiogenesis in the mouse lung. Am J Pathol 2000, 157(1):93-101. 1850204, 10880380.
108. Persson CG, Erjefalt JS, Korsgren M, Sundler F. The mouse trap. Trends Pharmacol Sci 1997, 18(12):465-467. 10.1016/S0165-6147(97)01142-5, 9458694.
109. Muessel MJ, Scott KS, Friedl P, Bradding P, Wardlaw AJ. CCL11 and GM-CSF differentially use the Rho GTPase pathway to regulate motility of human eosinophils in a three-dimensional microenvironment. J Immunol 2008, 180(12):8354-8360.
110. Rowe RG, Weiss SJ. Breaching the basement membrane: who, when and how?. Trends Cell Biol 2008, 18(11):560-574. 10.1016/j.tcb.2008.08.007, 18848450.
111. Burns AR, Smith CW, Walker DC. Unique structural features that influence neutrophil emigration into the lung. Physiol Rev 2003, 83(2):309-336.
112. Chun J, Prince A. Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration. J Leukoc Biol 2009, 86(5):1135-1144. 10.1189/jlb.0209072, 19605699.
113. Chun J, Prince A. TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. Cell Host Microbe 2009, 5(1):47-58. 10.1016/j.chom.2008.11.009, 2768384, 19154987.
114. Zen K, Parkos CA. Leukocyte-epithelial interactions. Curr Opin Cell Biol 2003, 15(5):557-564. 10.1016/S0955-0674(03)00103-0, 14519390.
115. Erjefalt JS, Korsgren M, Malm-Erjefalt M, Conroy DM, Williams TJ, Persson CG. Acute allergic responses induce a prompt luminal entry of airway tissue eosinophils. Am J Respir Cell Mol Biol 2003, 29(4):439-448. 10.1165/rcmb.2003-0015OC, 12663331.
116. Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, Bellettato CM, Papi A, Corbetta L, Zuin R, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 165(10):1404-1409. 10.1164/rccm.2107139, 12016104.
117. Taguchi M, Sampath D, Koga T, Castro M, Look DC, Nakajima S, Holtzman MJ. Patterns for RANTES secretion and intercellular adhesion molecule 1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J Exp Med 1998, 187(12):1927-1940. 10.1084/jem.187.12.1927, 2212358, 9625753.
118. Cyster JG. Chemorepulsion and thymocyte emigration. J Clin Invest 2002, 109(8):1011-1012. 150955, 11956237.
119. Vianello F, Kraft P, Mok YT, Hart WK, White N, Poznansky MC. A CXCR4-dependent chemorepellent signal contributes to the emigration of mature single-positive CD4 cells from the fetal thymus. J Immunol 2005, 175(8):5115-5125.
120. Caulfield J, Fernandez M, Snetkov V, Lee T, Hawrylowicz C. CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3+ T cells. Immunology 2002, 105(2):155-162. 10.1046/j.0019-2805.2001.01359.x, 1782655, 11872090.
121. Button B, Boucher RC. Role of mechanical stress in regulating airway surface hydration and mucus clearance rates. Respir Physiol Neurobiol 2008, 163(1-3):189-201. 10.1016/j.resp.2008.04.020, 2645865, 18585484.
122. Daviskas E, Anderson SD, Eberl S, Chan HK, Young IH. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest 2001, 119(2):414-421. 10.1378/chest.119.2.414, 11171717.
123. Bhowmik A, Chahal K, Austin G, Chakravorty I. Improving mucociliary clearance in chronic obstructive pulmonary disease. Respir Med 2009, 103(4):496-502. 10.1016/j.rmed.2008.10.014, 19091536.
124. Shah RV, Amin M, Sangwan S, Smaldone GC. Steroid effects on mucociliary clearance in outpatient asthma. J Aerosol Med 2006, 19(2):208-220. 10.1089/jam.2006.19.208, 16796545.
125. Bennett WD, Almond MA, Zeman KL, Johnson JG, Donohue JF. Effect of salmeterol on mucociliary and cough clearance in chronic bronchitis. Pulm Pharmacol Ther 2006, 19(2):96-100. 10.1016/j.pupt.2005.04.001, 15970448.
126. Sturton G, Persson C, Barnes PJ. Small airways: an important but neglected target in the treatment of obstructive airway diseases. Trends Pharmacol Sci 2008, 29(7):340-345. 10.1016/j.tips.2008.04.003, 18514920.
127. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004, 364(9435):709-721. 10.1016/S0140-6736(04)16900-6, 15325838.
128. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu AH, Wildfire JJ, Curry MD, Busse WW. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008, 372(9643):1065-1072. 10.1016/S0140-6736(08)61448-8, 2610850, 18805335.
129. Beeh KM, Beier J, Kornmann O, Mander A, Buhl R. Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD. Chest 2003, 123(3):778-783. 10.1378/chest.123.3.778, 12628878.
130. Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 2008, 63(6):493-499. 10.1136/thx.2007.086751, 18057097.
131. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002, 360(9347):1715-1721. 10.1016/S0140-6736(02)11679-5, 12480423.
132. Chlumsky J, Striz I, Terl M, Vondracek J. Strategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthma. J Int Med Res 2006, 34(2):129-139.
133. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E, Cartier A, Hussack P, Goldsmith CH, Laviolette M, Parameswaran K, Hargreave FE. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006, 27(3):483-494. 10.1183/09031936.06.00137704, 16507847.
134. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000, 161(1):64-72.
135. Leuppi JD, Salome CM, Jenkins CR, Anderson SD, Xuan W, Marks GB, Koskela H, Brannan JD, Freed R, Andersson M, Chan HK, Woolcock AJ. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001, 163(2):406-412.
136. Maneechotesuwan K, Essilfie-Quaye S, Kharitonov SA, Adcock IM, Barnes PJ. Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils. Chest 2007, 132(1):98-105. 10.1378/chest.06-2982, 17550933.
137. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008, 177(2):148-155. 10.1164/rccm.200707-1134OC, 17947611.
138. Lemiere C, Ernst P, Olivenstein R, Yamauchi Y, Govindaraju K, Ludwig MS, Martin JG, Hamid Q. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol 2006, 118(5):1033-1039. 10.1016/j.jaci.2006.08.003, 17088126.
139. Maestrelli P, Saetta M, Di Stefano A, Calcagni PG, Turato G, Ruggieri MP, Roggeri A, Mapp CE, Fabbri LM. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995, 152(6 Pt 1):1926-1931.
140. Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koeter GH, Postma DS. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000, 15(1):109-115. 10.1183/09031936.00.15110900, 10678630.
141. Tillie-Leblond I, Montani D, Crestani B, de Blic J, Humbert M, Tunon-de-Lara M, Magnan A, Roche N, Ostinelli J, Chanez P. Relation between inflammation and symptoms in asthma. Allergy 2009, 64(3):354-367. 10.1111/j.1398-9995.2009.01971.x, 19210358.
142. Barcelo B, Pons J, Fuster A, Sauleda J, Noguera A, Ferrer JM, Agusti AG. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2006, 145(3):474-479. 10.1111/j.1365-2249.2006.03167.x, 1809717, 16907916.
143. Barczyk A, Pierzchala W, Kon OM, Cosio B, Adcock IM, Barnes PJ. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2006, 117(6):1484-1492. 10.1016/j.jaci.2006.02.013, 16751017.
144. Freeman CM, Curtis JL, Chensue SW. CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity. Am J Pathol 2007, 171(3):767-776. 10.2353/ajpath.2007.061177, 1959492, 17640964.